Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LakePharma was a leading US-based biologics CRDMO specializing in integrated solutions spanning DNA vectors, viral vectors, cell lines, proteins, antibodies/mAbs and mRNA. It contributed to the development of over 200 therapeutic or diagnostic products and supported more than 1,500 customers—including most top global biopharmas—before being acquired by Curia in July 2021. Its expertise covered all major biologic modalities with significant capabilities in mammalian/microbial expression systems and advanced analytics. The company did not market its own therapeutics but enabled the pipelines of others.[2][3][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LakePharma.